Caxton Associates LLP Purchases 92,870 Shares of Neogen Corporation $NEOG

Caxton Associates LLP lifted its position in shares of Neogen Corporation (NASDAQ:NEOG) by 115.8% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 173,061 shares of the company’s stock after purchasing an additional 92,870 shares during the period. Caxton Associates LLP owned 0.08% of Neogen worth $1,608,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. UMB Bank n.a. grew its holdings in Neogen by 238.2% in the 4th quarter. UMB Bank n.a. now owns 6,422 shares of the company’s stock valued at $45,000 after buying an additional 4,523 shares in the last quarter. Hantz Financial Services Inc. increased its position in Neogen by 816.9% during the 4th quarter. Hantz Financial Services Inc. now owns 7,592 shares of the company’s stock worth $53,000 after buying an additional 6,764 shares during the period. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Neogen by 3,158.4% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 8,309 shares of the company’s stock worth $58,000 after buying an additional 8,054 shares in the last quarter. Los Angeles Capital Management LLC acquired a new stake in shares of Neogen during the fourth quarter worth $65,000. Finally, Merit Financial Group LLC bought a new stake in shares of Neogen in the fourth quarter valued at about $71,000. 96.73% of the stock is owned by institutional investors and hedge funds.

Neogen Trading Down 2.2%

Shares of NEOG stock opened at $9.40 on Friday. The stock has a market cap of $2.05 billion, a P/E ratio of -3.36, a price-to-earnings-growth ratio of 4.21 and a beta of 1.80. Neogen Corporation has a 1 year low of $4.56 and a 1 year high of $11.43. The company has a current ratio of 3.92, a quick ratio of 2.84 and a debt-to-equity ratio of 0.38. The stock has a 50 day simple moving average of $9.28 and a 200 day simple moving average of $9.55.

Analyst Ratings Changes

Several equities analysts recently commented on NEOG shares. Weiss Ratings downgraded shares of Neogen from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday. Wall Street Zen upgraded shares of Neogen from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $10.67.

Neogen Profile

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.